2Praml C,Amler LC,Dihlmann S,et al.Secretory typeⅡ phospholipase A2 (PLA2GⅡA) expression status in colorectal carcinoma derived cell lines and in normal colonic mucosa[J].Oncogene,1998,17(15):2009-2012.
3Graft JR,Konicek BW,Deddens JA,et al.Expression of group Ⅱ a secretory phospholipase A2 increases with prostate tumor grade[J].Clin Cancer Res,2001,7(12):3857-3861.
3Six DA,Dennis EA.The expanding superfamily of phospholipase A(2)enzymes:classification and characterization[J].Biochim Biophys Acta,2000,1488(1-2):1-19.
4Fijneman RJ,Peham JR,Van D,et al.Expression of Pla2g2a prevents carcinogenesis in Muc2-deficient mice[J].Cancer Sci,2008,99(11):2113-2119.
5Tribler L,Jensen LT,Jorgensen K,et al.Increased expression and activity of groupⅡA and X secretory phospholipase A2 in peritumoral versus central colon carcinoma tissue[J].Anticancer Res,2007,27(5A):3179-3185.
6Ganesan K,Ivanova T,Wu Y,et al.Inhibition of gastric cancer invasion and metastasis by PLA2G2A,a novel beta-catenin/TCF target gene[J].Cancer Res,2008,68(11):4277-4286.
8Leung SY,Chen X,Chu KM ,et al. Phospholilmse A2 group IIA expression in gastric adenoearcinoma is associated with prolonged survival and less frequent metastasis [J]. Proc Nail Aead Sci U S A,2002,99(25) : 16203-16208.
9Hoefi B, IAnseitmn J, Beckmann L, et al. Polymorphisms in fatty-acid-metabo- lism-related genes are associated with colorectal cancer risk [J]. Carcinogenesis,2010,31(3) : 466-472.
10Sved P,Scott KF,McLeod D,et al. Oncogenic action of secreted phospholipase A2 in prastate cancer [J]. Cancer Res,2004,64(19) : 6934-6940.
